5PSQ-016 Safe use of antiplatelet medication: approaching the optimal dose of aspirin by pharmaceutical intervention

BACKGROUND: Based on available evidence and its benefit/risk balance, acetylsalicylic acid (ASA) is the first-line antiplatelet drug of choice for secondary prevention of cardiovascular events. It is recommended to be used at low doses, not exceeding 150 mg/day. This dosage has proved to be effectiv...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Eur J Hosp Pharm
Main Authors: López-Álvarez, C, Ruiz-Fuentes, S, Domínguez-Recio, A, Blanco-Bermejo, C
Format: Artigo
Jezik:Inglês
Izdano: BMJ Group 2018
Teme:
Section 5: Patient safety and quality assurance
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535577/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.370
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki